As a leader in ZS’s value and access practice, Stefan develops solutions that enable clients to achieve market access for their innovations. Stefan also leads ZS’s New York office.
During his 16 years at ZS, Stefan has advised many large pharmaceutical companies as well as small to mid-size biotech companies on sales and marketing strategy and implementation.
Although Stefan has been working primarily with U.S.-based pharma clients during recent years, he has also been working on projects in many international markets and is familiar with key pharmaceutical markets in Europe, Asia and the Americas.
At ZS, Stefan engages with several thought leadership initiatives and supports many ZS project teams globally with his expertise on the global payer environment and with biosimilars.
Prior to his current role, Stefan was based in ZS’s Frankfurt office, where he worked on a broad range of sales and commercial strategy issues across European countries.
Stefan holds an MBA from INSEAD, and a B.A. and M.A. in economics from Cambridge University.